Jeffrey Bradley
Overview
Explore the profile of Jeffrey Bradley including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
84
Citations
3201
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Momin S, Lei Y, Tian Z, Roper J, Lin J, Kahn S, et al.
Phys Med Biol
. 2022 Mar;
67(8).
PMID: 35299156
Accurate segmentation of glioma and its subregions plays an important role in radiotherapy treatment planning. Due to a very populated multiparameter magnetic resonance imaging image, manual segmentation tasks can be...
12.
Zhang J, Sheng Y, Wolf J, Kayode O, Bradley J, Ge Y, et al.
Med Phys
. 2022 Feb;
49(4):2193-2202.
PMID: 35157318
Background: Knowledge-based planning (KBP) is increasingly implemented clinically because of its demonstrated ability to improve treatment planning efficiency and reduce plan quality variations. However, cases with large dose-volume histogram (DVH)...
13.
Contreras J, Srivastava A, Samson P, DeWees T, Govindan R, Baggstrom M, et al.
Int J Radiat Oncol Biol Phys
. 2022 Jan;
113(4):742-748.
PMID: 35074432
Purpose: Our purpose was to evaluate the maximum tolerated dose of hypofractionated proton beam radiation therapy with concurrent weekly carboplatin/paclitaxel in patients with stage II-III non-small cell lung cancer. Methods...
14.
Daly M, Singh N, Ismaila N, Antonoff M, Arenberg D, Bradley J, et al.
J Clin Oncol
. 2021 Dec;
40(12):1356-1384.
PMID: 34936470
Purpose: To provide evidence-based recommendations to practicing clinicians on management of patients with stage III non-small-cell lung cancer (NSCLC). Methods: An Expert Panel of medical oncology, thoracic surgery, radiation oncology,...
15.
Janopaul-Naylor J, Qian D, Khan M, Brown S, Lin J, Syed Y, et al.
Pract Radiat Oncol
. 2021 Jun;
11(5):325-327.
PMID: 34157450
The COVID-19 pandemic altered the workplace for medical education. As restrictions ease, the opportunities provided by virtual rotations remain. Radiation oncology rotations based on virtual participation with patients (consultations, follow-ups,...
16.
Lin Y, Lin B, Fu S, Folkerts M, Abel E, Bradley J, et al.
Phys Med Biol
. 2021 May;
66(12).
PMID: 34010818
Cancer radiotherapy (RT) with the irradiation at ultra-high dose rates, namely FLASH-RT, can substantially reduce radiation-induced normal tissue toxicities while maintaining tumor response. Currently, clinical FLASH-RT on deep-seated tumors can...
17.
Sands J, Mandrekar S, Kozono D, Oxnard G, Hillman S, Wigle D, et al.
Immunotherapy
. 2021 Apr;
13(9):727-734.
PMID: 33878954
Non-small-cell lung cancer (NSCLC) causes significant mortality each year. After successful resection of disease stage IB (>4 cm) to IIIA (per AJCC 7), adjuvant platinum-based chemotherapy improves median overall survival...
18.
Breneman J, Perentesis J, Bradley J, Mascia A, Abel E, Sharda A, et al.
Int J Radiat Oncol Biol Phys
. 2021 Mar;
110(5):1544-1545.
PMID: 33775856
No abstract available.
19.
Hassanzadeh C, Sita T, Savoor R, Samson P, Bradley J, Gentile M, et al.
J Thorac Dis
. 2020 Dec;
12(11):6690-6700.
PMID: 33282370
Background: Consolidation durvalumab improved overall survival (OS) in locally advanced non-small cell lung cancer (LA-NSCLC) treated with chemoradiotherapy (CRT) in the PACIFIC trial; however, pneumonitis was increased with durvalumab. We...
20.
Guckenberger M, Belka C, Bezjak A, Bradley J, Daly M, Deruysscher D, et al.
Int J Radiat Oncol Biol Phys
. 2020 Jun;
107(4):631-640.
PMID: 32589990
Background: The COVID-19 pandemic has caused radiotherapy resource pressures and led to increased risks for lung cancer patients and healthcare staff. An international group of experts in lung cancer radiotherapy...